Concepedia

Publication | Open Access

Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma

122

Citations

27

References

2012

Year

Abstract

Phase I study showed that intraventricular rituximab plus methotrexate is feasible and active in the treatment of refractory CNS lymphoma.

References

YearCitations

Page 1